Location History:
- Bayside, NY (US) (2005 - 2009)
- Cincinnati, OH (US) (2019 - 2024)
Company Filing History:
5 out of 13 
3 out of 14 
3 out of 3,539 
Years Active: 2005-2025
Title: The Innovative Contributions of Eric Jacobson
Introduction
Eric Jacobson is a prominent inventor based in Cincinnati, OH, known for his significant contributions to the field of immunology. With a total of eight patents to his name, Jacobson has made strides in developing vaccine compositions that enhance immune responses. His work is characterized by a focus on cationic lipid vaccine compositions, which have the potential to revolutionize how diseases are treated and prevented.
Latest Patents
Jacobson's latest patents include innovative methods of modulating immune responses using cationic lipid vaccine compositions. One patent details vaccine compositions that comprise at least one adjuvant and at least one therapeutic factor. This disclosure outlines methods for reducing immune suppressor cell populations in mammals, augmenting immune responses, and treating diseases using these vaccine compositions. Another patent focuses on vaccine compositions that include at least one adjuvant and one antigen, where the adjuvant is a cationic lipid. This patent also provides methods for treating and preventing diseases in mammals, as well as methods for inducing both humoral and cellular immune responses through antigen cross-presentation.
Career Highlights
Throughout his career, Jacobson has worked with notable companies such as PDS Biotechnology Corporation and Quadlogic Controls Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in vaccine technology.
Collaborations
Jacobson has collaborated with talented individuals in his field, including Kenya Johnson and Frank Bedu-Addo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new technologies.
Conclusion
Eric Jacobson's work in the field of immunology and vaccine development showcases his dedication to innovation and improving health outcomes. His patents reflect a commitment to advancing medical science and providing new solutions for disease prevention and treatment.